BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home » Authors » Larry Haimovitch

Articles by Larry Haimovitch

J.P. Morgan Healthcare 2012 Conference: Private companies make their pitches to receptive audience

Jan. 18, 2012
By Larry Haimovitch

2011 Canaccord Genuity Conference: Depsite struggling economy, aesthetics companies upbeat

Dec. 13, 2011
By Larry Haimovitch

Smaller companies pique the interest of Wells Fargo attendees

Aug. 1, 2011
By Larry Haimovitch

Smaller companies pique the interest of conference attendees

July 5, 2011
By Larry Haimovitch

For VC firms, FDA regulations at front of discussion topics

June 22, 2011
By Larry Haimovitch
SAN FRANCISCO — The 19th annual Medical Device Conference, sponsored by the influential law firm of Wilson Sonsini Goodrich & Rosati (WSG&R; Palo Alto, California) was held here this week at a new venue, the historic Palace Hotel in downtown San Francisco. (Medical Device Daily)
Read More

WSG&R presenters are hot and cold on med-tech funding

June 20, 2011
By Larry Haimovitch
SAN FRANCISCO — The 19th annual Medical Device Conference sponsored by the influential law firm of Wilson Sonsini Goodrich & Rosati (WSG&R; Palo Alto, California) was held here this week at a new venue, the historic Sheraton Palace in downtown San Francisco. (Medical Device Daily)
Read More

Atrial fibrillation still at the heart of annual HRS meeting

June 1, 2011
By Larry Haimovitch

CardioFocus demonstrates notable progress for AF

May 12, 2011
By Larry Haimovitch
SAN FRANCISCO — As discussed in Tuesday's issue of Medical Device Daily, there has been considerable progress in treating atrial fibrillation (AF) with catheter-based technologies in recent years. However, the rate of success, estimated at 57% for a single procedure, is far from satisfactory. Thus, the quest for better methods to perform AF catheter ablation continues at a strong pace. One company, which is demonstrating impressive progress, is privately-owned, venture capital-backed CardioFocus (Marlborough, Massachusetts). (Medical Device Daily)
Read More

AF still at the heart of annual HRS meeting

May 10, 2011
By Larry Haimovitch
SAN FRANCISCO — As has been the case in recent years, the 32nd annual scientific sessions of the Heart Rhythm Society (HRS; Washington) sponsored an AF Summit, focusing attention on atrial fibrillation (AF) with a full day of presentations. (Medical Device Daily)
Read More

Presenters tout big advances with lasers in cataract surgery

March 29, 2011
By Larry Haimovitch
Previous 1 2 3 4 5 6 7 8 9 … 18 19 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • Woman and 3D brain

    Astellas’ ASP-2246 shows promise in stroke management

    BioWorld Science
    Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for Feb. 10, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing